The solutions and services it provides for its blood center clients uses advanced systems that offer scalability, and enable for quick processing of diagnostic results. It allows staff and technicians at blood testing and transfusion labs easily collect any blood component in any combination. The flexibility of the medical and hemostasis equipment allows blood separation to be seamless, and this enhances the quality and security of blood for transfusion recipients. All processes are automated to improve overall productivity and business results of clients. Terumo BCT’s solutions allow their users to save time and create new revenue streams that bring in profit to their organizations.
Terumo BCT has been riding a train of success ever since its inception, and the firm has over 700 granted patents for its superior solutions in the blood collection and testing arena. The company also has more than 100 pending patents for the future platforms and equipment in plans to release in this domain.
Terumo BCT creates blood collection and blood sampling solutions that make blood transfusions safer, affordable, and available to more people around the globe
One product that Terumo BCT has in operation at various hospitals and clinical blood diagnostic centers is their automated blood collection system – “Trima Accel.” The medical apparatus is redefining the entire apheresis experience and has capabilities to collect blood components in any combination. It empowers professionals in the blood testing industry to collect more platelets per donor and improves the quality of the blood for transfusion. The software that is utilized to run the system is smart tech-enabled, and this allows for quick delivery of diagnostic results.
Terumo BCT through their automated blood processing system- -”Reveous”—improves operations and delivers impressive benefits at blood centers. It is easily installed at diagnostic centers, and the automation of the manufacturing system enables for the Reveous system to effortlessly process blood components from whole blood units. The solution comes in four parts. The first part is a stand-alone device that can run tests on four units of blood in a single cycle. The next is the Reveous System Manager (RSM), software that controls the workflow for each device, and enables its reporting capabilities. IT also has a 3 component blood bag set that is utilized for both blood collection, and component processing besides offering leukoreduction capabilities. The final piece is the platelet pooling set that is used to dispose of leukoreduce.
Moving into the future, the team at Terumo BCT is continuing to research the possibilities of unlocking the full potential of blood testing to develop solutions and devices that will offer a superior diagnosis to medical practitioners across the globe. A physician can use these results to further intervene in a patient’s disease state and select the prime course of action to enhance the quality of the patient’s life or increase life longevity.